Prolonged dopamine and serotonin transporter inhibition after exposure to tropanes

Neuropharmacology

Volumn 37, Issue 1, 1998, Pages 123-130

  Bennett, Barbara A ^a   Hollingsworth, Charlotte K ^a   Martin, R Shayn ^a   Childers, Steven R ^a   Ehrenkaufer, Richard E ^a   Porrino, Linda J ^a   Davies, Huw M l ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Clearance half life; Cocaine; Dopamine transporters; Serotonin transporters; Tropanes

Indexed keywords

3BETA (2 NAPHTHYL) 2BETA PROPIONYLTROPANE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTER; TROPANE DERIVATIVE; UNCLASSIFIED DRUG; WF 11; WF 31;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOPAMINE UPTAKE; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; STEREOTYPY;

ANIMALS; BRAIN; CARRIER PROTEINS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RATS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TROPANES;

EID: 0031808621     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00194-9     Document Type: Article

References (20)

1. Arnt J., Christensen A.V., Hyttel J. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 329:1985;101-107.
2. Bennett B.A., Wichems C.H., Hollingsworth C.K., Davies H.M.L., Thornley C., Sexton T., Childers S.R. Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. J. Pharmacol. Exp. Ther. 272:1995;1176-1186.
3. Bennett B.A., Paris J.M., Pecora J.R. Stimulant-induced alterations in dopaminergic and serotonergic function in fetal raphe neurons. Brain Res. Bull. 31:1993;471-476.
4. Bonnet J.-J., Costentin J. GBR12783, a potent and selective inhibitor of dopamine uptake: biochemical studies in vivo and ex vivo. Eur. J. Pharmacol. 121:1986;199-209.
5. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Daunais, J.B., Hart, S.L., Smith, H.R., Letchworth, S.R., Davies, H.M.L., Sexton, T., Bennett, B.A., Childers, S.R., Porrino, L.J., 1998. Long-acting blockade of biogenic amine transporters in rat brain by administration of the potent novel tropane WF-23 (2β-propanoyl-3β-(2-naphthyl)-tropane). J. Pharmacol. Exp. Ther., (in press).
7. Davies H.M.L., Saikali E., Huby N.J.S., Gilliatt V.J., Matasi J.J., Sexton T., Childers S.R. Synthesis of 2β-Acyl-3β-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. J. Med. Chem. 37:1994;1262-1268.
8. Davies H.M.L., Saikali E., Sexton T., Childers S.R. Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum. Eur. J. Pharmacol. 244:1993;93-97.
9. Fleckenstein A.E., Carroll F.I., Pögün S., Kuhar M.J. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3β-(3p-chlorophenyl)tropan-2β-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]. J. Pharmacol. Exp. Ther. 279:1996;200-206.
10. Hemby S.E., Reboussin D., Davies H.M.L., Dworkin S.I., Smith J.E. Comparison of a novel tropane analog of cocaine, 2β-propanoyl-3β-(4-tolyl)tropane (PTT) with cocaine HCl in rats: nucleus accumbens extracellular dopamine concentration and motor activity. J. Pharmacol. Exp. Ther. 273:1995;656-666.
11. Kraak J.C., Van Rooij H.H., Thus J.L.G. Reversed-phase ion-pair systems for the prediction of n-octanol-water partition coefficients of basic compounds by high-performance liquid chromatography. J. Chromatogr. 352:1986;455-461.
12. 18F]PNBS) in rats. Nucl. Med. Biol. 20:1993;269-278.
13. Leo A, Hansch C., Elkins D. Partition coefficients and their uses. Chem. Rev. 71:1971;525.
14. Morrison J.F., Walsh C.T. The behavior and significance of slow-binding enzyme inhibitors. Meister A. Advances in Enzymology and Related Areas of Molecular Biology. 61:1988;201-310 Wiley, New York.
15. Porrino L.J., Migliarese K., Davies H.M.L., Saikali E., Childers S.R. Behavioral effects of the novel tropane analog, 2β-propanoyl-3β-(4-toluyl)-tropane (PTT). Life Sci. 54:1994;511-517.
16. Porrino L.J., Davies H.M.L., Childers S.R. Behavioral and local cerabral metabolic effects of the novel tropane analog, 2β-propanoyl-3β-(4-toluyl)-tropane. J. Pharm. Exp. Ther. 272:1995;901-910.
17. Rosenzweig-Lipson S., Bergman J., Spealman R.D., Madras B.D. Stereoselective behavioral effects of Lu 19-005 in monkeys: relation to binding at cocaine recognition sites. Psychopharm. 107:1992;186-194.
18. Rothman R.B., Mele A., Reid A.A. et al. Tight binding dopamine reuptake inhibitors as cocaine antagonists. A strategy for drug development. FEBS Lett. 257:1989;341-344.
19. Rothman R.B., Mele A., Reid A.A. et al. GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol. Biochem. Behav. 40:1991;387-397.
20. Volkow N.D., Gatley S.J., Fowler J.S. et al. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3β-(4-Iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or βcit. Synapse. 19:1995;206-211.